Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease?

Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease?

Epidemiological data strongly support the inverse association between high-density lipoprotein cholesterol concentration and cardiovascular risk. Over the last three decades, pharmaceutical strategies have been partially successful in raising high-density lipoprotein cholesterol concentration, but c...

Full description

Bibliographic Details
Main Author:	Martin B Whyte
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-08-01
Series:	JRSM Cardiovascular Disease
Online Access:	https://doi.org/10.1177/2048004019869736

Similar Items

Neutrophils as a Novel Target of Modified Low-Density Lipoproteins and an Accelerator of Cardiovascular Diseases
by: Takashi Obama, et al.
Published: (2020-11-01)

High-density lipoproteins: a novel therapeutic target for cardiovascular disease
by: TS Mohamed Saleem, et al.
Published: (2011-01-01)

HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE
by: Stephen J. Nicholls, et al.
Published: (2020-10-01)

Aggregation Susceptibility of Low-Density Lipoproteins—A Novel Modifiable Biomarker of Cardiovascular Risk
by: Katariina Öörni, et al.
Published: (2021-04-01)

High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
by: Navin K Kapur, et al.
Published: (2008-02-01)

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
by: Fumiaki Ito, et al.
Published: (2020-04-01)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future
by: Josep Julve, et al.
Published: (2021-07-01)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future
by: Josep Julve, et al.
Published: (2021-07-01)

The role of level and function of High Density Lipoprotein (HDL) in Cardiovascular Diseases
by: Malihe Aghasizadeh, et al.
Published: (2020-06-01)

Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
by: Diego Estrada-Luna, et al.
Published: (2018-10-01)

Research progress of monocyte/high density lipoprotein ratio in cardiovascular diseases
by: Wan-Yue Sang, et al.
Published: (2021-05-01)

The Impact of Lipoprotein Apheresis on Oxidative Stress Biomarkers and High-Density Lipoprotein Subfractions
by: Agnieszka Mickiewicz, et al.
Published: (2020-01-01)

Molecular mechanisms of high-density lipoprotein biogenesis, metabolism and function: relevance to cardiovascular disease prevention and treatment
by: Nyholt, Dana
Published: (2011)

Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
by: Karin Kornmueller, et al.
Published: (2019-08-01)

Small Dense Low-Density Lipoprotein: Biomarker or Potential Drug Target?
by: Basabdatta Samanta
Published: (2019-04-01)

The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases
by: Ya D Babintseva, et al.
Published: (2016-09-01)

High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease
by: Constantine E Kosmas, et al.
Published: (2018-03-01)

Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
by: Ekaterina A. Ivanova, et al.
Published: (2017-01-01)

Oxidized and electronegative low-density lipoprotein as potential biomarkers of cardiovascular risk in obese adolescents
by: Maria Camila Pruper de Freitas, et al.
Published: (2018-10-01)

Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease
by: Alexander N. Orekhov, et al.
Published: (2014-07-01)

Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
by: Yi-Heng Li, et al.
Published: (2020-12-01)

Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?
by: Susana Coimbra, et al.
Published: (2021-05-01)

Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery
by: Lin Cui, et al.
Published: (2018-01-01)

High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease: effect of exercise training
by: Nayoung Ahn, et al.
Published: (2016-09-01)

High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease1
by: Meliana Riwanto, et al.
Published: (2013-12-01)

High-Density Lipoproteins in Kidney Disease
by: Valentina Kon, et al.
Published: (2021-07-01)

High density lipoproteins in liver disease
by: Khalil Ibrahim, M. G. E. I.
Published: (1984)

High-Density Lipoprotein-Targeted Therapies for Heart Failure
by: Mudit Mishra, et al.
Published: (2020-12-01)

Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.
by: E J Schaefer, et al.
Published: (1981-02-01)

Roles of Reconstituted High-Density Lipoprotein Nanoparticles in Cardiovascular Disease: A New Paradigm for Drug Discovery
by: Jiansheng Huang, et al.
Published: (2020-01-01)

Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases
by: Mark L. Schultz, et al.
Published: (2019-11-01)

Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease
by: A. E. Nikitin, et al.
Published: (2020-03-01)

Low-Density Lipoprotein Cholesterol Target Attainment in Patients With Established Cardiovascular Disease: Analysis of Routine Care Data
by: Groenhof, T Katrien J, et al.
Published: (2020-04-01)

Lipoprotein(a) in Cardiovascular Diseases
by: Michele Malaguarnera, et al.
Published: (2013-01-01)

High density lipoprotein metabolism in health and disease
by: Atmeh, R. F.
Published: (1982)

Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein.
by: I Jialal, et al.
Published: (1989-10-01)

Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease
by: Chiz-Tzung Chang, et al.
Published: (2015-01-01)

Analysis of high density lipoproteins by a modified gradient gel electrophoresis method.
by: Z Li, et al.
Published: (1994-09-01)

High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
by: Philip J. Barter
Published: (2013-09-01)

Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study
by: Karimollah Hajian-Tilaki, et al.
Published: (2020-01-01)